LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,050 | -2.2% | 923,771 | +0.5% | 0.97% | +6.3% |
| Q2 2023 | $63,438 | +23.7% | 918,992 | -13.6% | 0.91% | +21.4% |
| Q1 2023 | $51,287 | +8.5% | 1,063,610 | +12.4% | 0.75% | +11.5% |
| Q4 2022 | $47,249 | -99.9% | 946,500 | +0.6% | 0.67% | +25.8% |
| Q3 2022 | $38,405,000 | +663.1% | 941,300 | +928.7% | 0.53% | +662.9% |
| Q2 2022 | $5,033,000 | +61.1% | 91,500 | +6.4% | 0.07% | +100.0% |
| Q1 2022 | $3,125,000 | -45.2% | 86,000 | -35.9% | 0.04% | -35.2% |
| Q2 2020 | $5,707,000 | – | 134,100 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |